VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Jan 17, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-01-16

Reporting Person: LEIDEN JEFFREY M (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-16	Common Stock	M	45000	$29.98	Acquired	227925	Direct
2014-01-16	Common Stock	S	45000	$80.00	Disposed	182925	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-16	Stock Option	$29.98	M	45000	Disposed	2021-12-13	Common Stock (45000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	440	Indirect

Footnotes

F1: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F2: The option vests in 16 quarterly installments from 12/14/2011.